Glück Conviction Score™ ⓘ
MBX
MBX Biosciences, Inc.
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
37,9
34 neu, 42 erhöht, 8,7M $ netto
Aktivist
37,3
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 32.38 | +9.7 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 28.05 | +26.6 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 32.19 | EMA50: 32.17 | |
| MACD-Histogramm | Bullisch | 10 % | 0.496 | Bullisch | |
| RSI(14) | Neutral | 10 % | 59.6 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 81.0 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 13.3 | +DI: 28.2 / −DI: 14.1 | |
| Z-Score(60) | Neutral | 5 % | 1.33 | In Range | |
| 52W-Position | Neutral | 5 % | 77.2 % | Hoch 43.14 / Tief 9.73 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 104.2 % | Upper 35.20 / Mid 31.55 / Lower 27.91 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0472 | R²=0.09 / annualisiert +37.5 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | Azoulay Salomon | Officer, Chief Medical Officer | Open Market Sale | -15.003 | 38,30 | -574.614,90 | -29,1% | |
| 2026-05-08 | Azoulay Salomon | Officer, Chief Medical Officer | Open Market Sale | -55.000 | 38,38 | -2.110.900,00 | -107,1% | |
| 2026-05-06 | Hawryluk P. Kent | Director, Officer, President & CEO | Open Market Sale | -607 | 29,54 | -17.930,78 | -0,9% | |
| 2026-05-06 | Azoulay Salomon | Officer, Chief Medical Officer | Open Market Sale | -231 | 29,54 | -6.823,74 | -0,3% | |
| 2026-03-13 | Hawryluk P. Kent | Director, Officer, President & CEO | Open Market Purchase | 18.500 | 28,41 | 525.662,70 | +26,7% | |
| 2025-10-20 | Hawryluk P. Kent | Director, Officer, President & CEO | Open Market Purchase | 20.000 | 13,64 | 272.790,00 | +13,8% | |
| 2025-10-17 | Hoerter Steven L. | Director | Open Market Purchase | 20.000 | 13,25 | 264.984,00 | +13,4% | |
| 2025-09-26 | Heron Patrick J | Director, 10% Owner | Open Market Purchase | 666.666 | 18,00 | 11.999.988,00 | +608,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.652.013 | 6.652.013 | 0 | 198.562.588 | Unverändert | 0,0% | |
| ORBIMED ADVISORS LLC | 3.637.887 | 3.935.203 | -297.316 | 108.590.927 | Reduziert | -7,6% | |
| NEA Management Company, LLC | 3.614.486 | 3.614.486 | 0 | 107.892.407 | Unverändert | 0,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 3.191.824 | 3.349.961 | -158.137 | 95.275.947 | Reduziert | -4,7% | |
| BlackRock, Inc. | 2.941.406 | 2.919.756 | 21.650 | 87.800.969 | Aufgestockt | +0,7% | |
| FMR LLC | 2.936.684 | 15.746 | 2.920.938 | 87.660.017 | Aufgestockt | +18550,3% | |
| Deep Track Capital, LP | 2.757.569 | 3.249.790 | -492.221 | 82.313.435 | Reduziert | -15,1% | |
| NVP Associates, LLC | 2.136.335 | 2.136.335 | 0 | 63.769.600 | Unverändert | 0,0% | |
| VANGUARD GROUP INC | 1.817.811 | 0 | 1.817.811 | 57.333.759 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 1.622.186 | 0 | 1.622.186 | 48.422.252 | Neu | +100,0% | |
| BRAIDWELL LP | 1.492.467 | 1.018.600 | 473.867 | 44.550.140 | Aufgestockt | +46,5% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.477.592 | 0 | 1.477.592 | 44.106.121 | Neu | +100,0% | |
| Aaron Wealth Advisors LLC | 1.168.176 | 70.000 | 1.098.176 | 34.870.054 | Aufgestockt | +1568,8% | |
| Cormorant Asset Management, LP | 1.120.000 | 1.120.000 | 0 | 33.432.000 | Unverändert | 0,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.018.212 | 1.408.159 | -389.947 | 30.393.628 | Reduziert | -27,7% | |
| CITADEL ADVISORS LLC | 968.033 | 835.357 | 132.676 | 28.895.785 | Aufgestockt | +15,9% | |
| Kynam Capital Management, LP | 934.799 | 934.799 | 0 | 27.903.750 | Unverändert | 0,0% | |
| Woodline Partners LP | 900.063 | 1.000.063 | -100.000 | 26.866.881 | Reduziert | -10,0% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 890.000 | 890.000 | 0 | 26.566.500 | Unverändert | 0,0% | |
| Caligan Partners LP | 848.590 | 0 | 848.590 | 25.330.412 | Neu | +100,0% | |
| Parkman Healthcare Partners LLC | 800.037 | 885.639 | -85.602 | 23.881.104 | Reduziert | -9,7% | |
| STATE STREET CORP | 787.208 | 672.740 | 114.468 | 23.498.159 | Aufgestockt | +17,0% | |
| EcoR1 Capital, LLC | 777.000 | 2.123.604 | -1.346.604 | 23.193.450 | Reduziert | -63,4% | |
| Point72 Asset Management, L.P. | 680.609 | 0 | 680.609 | 21.466.408 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 670.385 | 649.391 | 20.994 | 20.015.778 | Aufgestockt | +3,2% | |
| TCG Crossover Management, LLC | 650.000 | 650.000 | 0 | 19.402.500 | Unverändert | 0,0% | |
| MILLENNIUM MANAGEMENT LLC | 564.415 | 462.049 | 102.366 | 16.847.788 | Aufgestockt | +22,2% | |
| STEMPOINT CAPITAL LP | 499.469 | 78.553 | 420.916 | 14.909.150 | Aufgestockt | +535,8% | |
| GOLDMAN SACHS GROUP INC | 457.945 | 331.938 | 126.007 | 13.669.658 | Aufgestockt | +38,0% | |
| UBS Group AG | 346.914 | 281.212 | 65.702 | 10.355.383 | Aufgestockt | +23,4% | |
| Trails Edge Capital Partners, LP | 315.158 | 0 | 315.158 | 9.940.084 | Neu | +100,0% | |
| Candriam S.C.A. | 294.374 | 0 | 294.374 | 8.787.064 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 288.889 | 671.838 | -382.949 | 8.623.337 | Reduziert | -57,0% | |
| Rock Springs Capital Management LP | 287.967 | 282.624 | 5.343 | 8.595.815 | Aufgestockt | +1,9% | |
| Opaleye Management Inc. | 260.000 | 260.000 | 0 | 7.761.000 | Unverändert | 0,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 214.908 | 222.180 | -7.272 | 6.415.004 | Reduziert | -3,3% | |
| Elmind Capital, LP | 211.000 | 211.000 | 0 | 6.298.350 | Unverändert | 0,0% | |
| NORTHERN TRUST CORP | 210.575 | 190.881 | 19.694 | 6.285.665 | Aufgestockt | +10,3% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 208.049 | 0 | 208.049 | 6.210.263 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 178.897 | 408.900 | -230.003 | 5.340.075 | Reduziert | -56,2% | |
| DAFNA Capital Management LLC | 175.465 | 165.265 | 10.200 | 5.237.630 | Aufgestockt | +6,2% | |
| 683 Capital Management, LLC | 158.800 | 0 | 158.800 | 5.008.552 | Neu | +100,0% | |
| Goelzer Investment Management, Inc. | 164.172 | 221.672 | -57.500 | 4.900.535 | Reduziert | -25,9% | |
| Affinity Asset Advisors, LLC | 150.000 | 250.000 | -100.000 | 4.477.500 | Reduziert | -40,0% | |
| Tetragon Partners GP Ltd | 145.480 | 143.327 | 2.153 | 4.342.578 | Aufgestockt | +1,5% | |
| BALYASNY ASSET MANAGEMENT L.P. | 119.726 | 0 | 119.726 | 3.776.158 | Neu | +100,0% | |
| Schonfeld Strategic Advisors LLC | 123.814 | 167.125 | -43.311 | 3.695.846 | Reduziert | -25,9% | |
| KVP Capital Advisors, LP | 121.524 | 121.524 | 0 | 3.627.491 | Unverändert | 0,0% | |
| TD ASSET MANAGEMENT INC | 115.998 | 101.450 | 14.548 | 3.462.540 | Aufgestockt | +14,3% | |
| TWO SIGMA INVESTMENTS, LP | 115.075 | 138.571 | -23.496 | 3.434.989 | Reduziert | -17,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.652.013 | 6.652.013 | 0,0% | 198.562.588 | 13,04 |
| ORBIMED ADVISORS LLC | 3.637.887 | 3.935.203 | -7,6% | 108.590.927 | 7,13 |
| NEA Management Company, LLC | 3.614.486 | 3.614.486 | 0,0% | 107.892.407 | 7,09 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.191.824 | 3.349.961 | -4,7% | 95.275.947 | 6,26 |
| BlackRock, Inc. | 2.941.406 | 2.919.756 | +0,7% | 87.800.969 | 5,77 |
| FMR LLC | 2.936.684 | 15.746 | +18550,3% | 87.660.017 | 5,76 |
| Deep Track Capital, LP | 2.757.569 | 3.249.790 | -15,1% | 82.313.435 | 5,41 |
| NVP Associates, LLC | 2.136.335 | 2.136.335 | 0,0% | 63.769.600 | 4,19 |
| Polar Capital Holdings Plc | 1.622.186 | 0 | +100,0% | 48.422.252 | 3,18 |
| BRAIDWELL LP | 1.492.467 | 1.018.600 | +46,5% | 44.550.140 | 2,93 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.477.592 | 0 | +100,0% | 44.106.121 | 2,90 |
| Aaron Wealth Advisors LLC | 1.168.176 | 70.000 | +1568,8% | 34.870.054 | 2,29 |
| Cormorant Asset Management, LP | 1.120.000 | 1.120.000 | 0,0% | 33.432.000 | 2,20 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.018.212 | 1.408.159 | -27,7% | 30.393.628 | 2,00 |
| CITADEL ADVISORS LLC | 968.033 | 835.357 | +15,9% | 28.895.785 | 1,90 |
| Kynam Capital Management, LP | 934.799 | 934.799 | 0,0% | 27.903.750 | 1,83 |
| Woodline Partners LP | 900.063 | 1.000.063 | -10,0% | 26.866.881 | 1,76 |
| EVENTIDE ASSET MANAGEMENT, LLC | 890.000 | 890.000 | 0,0% | 26.566.500 | 1,74 |
| Caligan Partners LP | 848.590 | 0 | +100,0% | 25.330.412 | 1,66 |
| Parkman Healthcare Partners LLC | 800.037 | 885.639 | -9,7% | 23.881.104 | 1,57 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 156 | 55,5 | 1.625 |
| 31.12.2025 | ✓ | 139 | 49,3 | 1.527 |
| 30.09.2025 | ✓ | 124 | 50,0 | 856 |
| 30.06.2025 | ✓ | 86 | 36,8 | 402 |
| 31.03.2025 | ✓ | 77 | 35,8 | 256 |
| 31.12.2024 | ✓ | 62 | 33,0 | 585 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| BRAIDWELL LP | 1.018.600 | 32.126.644 |
| EVENTIDE ASSET MANAGEMENT, LLC | 890.000 | 28.070.600 |
| D. E. Shaw & Co., Inc. | 671.838 | 21.189.771 |
| Trails Edge Capital Partners, LP | 315.158 | 9.940.084 |
| Opaleye Management Inc. | 260.000 | 8.200.400 |
| Goelzer Investment Management, Inc. | 221.672 | 6.991.535 |
| Elmind Capital, LP | 211.000 | 6.654.940 |
| KVP Capital Advisors, LP | 121.524 | 3.832.867 |
| OSAIC HOLDINGS, INC. | 77.601 | 2.447.371 |
| Squarepoint Ops LLC | 46.702 | 1.472.981 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BlackRock, Inc. | 2.919.756 | 962.295 | +49.2 % | 92.089.105 |
| STATE STREET CORP | 672.740 | 353.466 | +110.7 % | 21.218.220 |
| UBS Group AG | 281.212 | 220.487 | +363.1 % | 8.869.427 |
| GEODE CAPITAL MANAGEMENT, LLC | 649.391 | 175.459 | +37.0 % | 20.486.608 |
| VANGUARD GROUP INC | 1.817.811 | 140.449 | +8.4 % | 57.333.759 |
| Soleus Capital Management, L.P. | 408.900 | 133.900 | +48.7 % | 12.896.706 |
| TWO SIGMA INVESTMENTS, LP | 138.571 | 124.984 | +919.9 % | 4.370.529 |
| Parkman Healthcare Partners LLC | 885.639 | 112.335 | +14.5 % | 27.933.054 |
| Deep Track Capital, LP | 3.249.790 | 99.790 | +3.2 % | 102.498.377 |
| BALYASNY ASSET MANAGEMENT L.P. | 119.726 | 94.085 | +366.9 % | 3.776.158 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 3.349.961 | -1.473.375 | -30.5 % | 105.657.771 |
| Kynam Capital Management, LP | 934.799 | -1.065.201 | -53.3 % | 29.483.560 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 354.428 | -335.572 | -48.6 % | 11.178.659 |
| CITADEL ADVISORS LLC | 835.357 | -293.826 | -26.0 % | 26.347.160 |
| MILLENNIUM MANAGEMENT LLC | 462.049 | -218.367 | -32.1 % | 14.573.025 |
| Woodline Partners LP | 1.000.063 | -201.087 | -16.7 % | 31.541.987 |
| GROUP ONE TRADING LLC | 29.128 | -156.772 | -84.3 % | 918.697 |
| PFM Health Sciences, LP | 79.310 | -142.195 | -64.2 % | 2.501.437 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.408.159 | -131.480 | -8.5 % | 44.413.335 |
| 683 Capital Management, LLC | 158.800 | -125.000 | -44.0 % | 5.008.552 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 06.05.2026 | Abigail P. Johnson | Passiv (13G) | 6,20 % | 2.936.684 | Neu | |
| 06.05.2026 | FMR LLC | Passiv (13G) | 6,20 % | 2.936.684 | Neu | |
| 27.04.2026 | BlackRock, Inc. | Passiv (13G/A) | 4,80 % | 2.287.497 | -0,30 pp | |
| 11.02.2026 | OrbiMed Genesis GP LLC | Aktivist (13D/A) | 1,40 % | 679.887 | -0,30 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … |
| 11.02.2026 | ORBIMED ADVISORS LLC | Aktivist (13D/A) | 7,70 % | 3.637.887 | -1,30 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … |
| 11.02.2026 | ORBIMED CAPITAL GP VII LLC | Aktivist (13D/A) | 6,30 % | 2.958.000 | -1,00 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … |
| 10.02.2026 | Wellington Management Company LLP | Passiv (13G/A) | 7,30 % | 3.349.961 | -3,30 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 7,50 % | 3.349.961 | -3,30 pp | |
| 10.02.2026 | Wellington Management Group LLP | Passiv (13G/A) | 7,50 % | 3.349.961 | -3,30 pp | |
| 10.02.2026 | Wellington Group Holdings LLP | Passiv (13G/A) | 7,50 % | 3.349.961 | -3,30 pp | |
| 21.01.2026 | BlackRock, Inc. | Passiv (13G) | 5,10 % | 2.271.161 | Neu | |
| 14.11.2025 | P. Kent Hawryluk | Passiv (13G/A) | 4,30 % | 1.995.759 | Neu | |
| 12.11.2025 | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | Passiv (13G/A) | 4,50 % | 2.017.394 | -1,12 pp | |
| 10.11.2025 | Anthony A. Florence, Jr. | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Paul Walker | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Rick Yang | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Scott D. Sandell | Aktivist (13D/A) | 8,10 % | 3.614.486 | Neu | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Carmen Chang | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Edward T. Mathers | Aktivist (13D/A) | 8,10 % | 3.619.474 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Ali Behbahani | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | New Enterprise Associates 17, L.P. | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Forest Baskett | Aktivist (13D/A) | 8,10 % | 3.614.486 | Neu | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | NEA 17 GP, LLC | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | NEA Partners 17, L.P. | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 10.11.2025 | Mohamad H. Makhzoumi | Aktivist (13D/A) | 8,10 % | 3.614.486 | -3,30 pp | NEA 17 acquired the NEA 17 Shares for investment purposes. Depending on market condition… |
| 06.10.2025 | Wellington Management Group LLP | Passiv (13G/A) | 10,80 % | 4.823.336 | +4,00 pp | |
| 06.10.2025 | Wellington Group Holdings LLP | Passiv (13G/A) | 10,80 % | 4.823.336 | +4,00 pp | |
| 06.10.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 10,80 % | 4.823.336 | +4,00 pp | |
| 06.10.2025 | Wellington Management Company LLP | Passiv (13G/A) | 10,60 % | 4.823.336 | +3,80 pp | |
| 30.09.2025 | Genesis VC Partners XVI, LLC | Aktivist (13D/A) | 4,80 % | 2.136.335 | -1,60 pp | |
| 30.09.2025 | NVP Associates, LLC | Aktivist (13D/A) | 4,80 % | 2.136.335 | -1,60 pp | |
| 30.09.2025 | Norwest Venture Partners XVI, LP | Aktivist (13D/A) | 4,80 % | 2.136.335 | -1,60 pp | |
| 30.09.2025 | Tiba Aynechi | Aktivist (13D/A) | 4,80 % | 2.140.989 | -1,60 pp | |
| 30.09.2025 | Jeffrey Crowe | Aktivist (13D/A) | 4,80 % | 2.136.335 | -1,60 pp | |
| 30.09.2025 | Jon Erik Kossow | Aktivist (13D/A) | 4,80 % | 2.136.335 | Neu | |
| 30.09.2025 | Frazier Life Sciences X, L.P. | Aktivist (13D/A) | 11,70 % | 5.219.440 | -1,90 pp | |
| 30.09.2025 | FHMLSP Overage, L.L.C. | Aktivist (13D/A) | 0,70 % | 325.653 | -0,30 pp | |
| 30.09.2025 | Frazier Life Sciences XI, L.P. | Aktivist (13D/A) | 0,00 % | 3.000 | 0,00 pp | |
| 30.09.2025 | Patrick J. Heron | Aktivist (13D/A) | 11,70 % | 5.224.095 | -1,90 pp | |
| 30.09.2025 | FHMLSP, L.P. | Aktivist (13D/A) | 2,50 % | 1.103.920 | -0,80 pp |
Stammdaten
MBX Biosciences, Inc., ein Biopharmaunternehmen in der klinischen Phase, konzentriert sich auf die Entdeckung und Entwicklung von Präzisions-Peptidtherapien zur Behandlung von endokrinen und Stoffwechselerkrankungen. Sein führender Produktkandidat ist MBX 2109, ein Nebenschilddrüsenhormon-Peptid-Prodrug, das sich in Phase-2-Studien befindet und als potenzielle langwirkende Hormonersatztherapie zur Behandlung von chronischem Hypoparathyreoidismus ausgelegt ist. Das Unternehmen entwickelt auch MBX 1416, einen langwirkenden Glucagon-ähnlichen Peptid-1 (GLP-1)-Rezeptorantagonisten, der sich in Phase-1-Studien befindet und als potenzielle Therapie für postbariatrische Hypoglykämie, eine chronische Komplikation der bariatrischen Chirurgie, ausgelegt ist. Außerdem entwickelt es MBX 4291, einen führenden Adipositas-Produktkandidaten, der sich in Studien zur Genehmigung investigativer Arzneimittel befindet und als langwirkender und hochpotenter GLP-1- und Glucose-abhängiger Insulinotroper-Polypeptid-Rezeptor-Co-Agonist-Prodrug zur Behandlung von Adipositas und Begleiterkrankungen ausgelegt ist. Das Unternehmen wurde 2018 gegründet und ist in Carmel, Indiana, ansässig.
Unternehmen & Branche
| Name | MBX Biosciences, Inc. |
|---|---|
| Ticker | MBX |
| CIK | 0001776111 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 55287L101 |
|---|---|
| ISIN | US55287L1017 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,67 Mrd. USD |
Bewertung
| KBV (P/B) | 4,53 |
|---|---|
| FCF-Rendite | -4,9 % |
Qualität & Bilanz
| ROIC | -23,5 % |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2023. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|
| Bewertung | ||||
| KBV (P/B) | – | 2,39 | 3,84 | |
| FCF-Rendite | – | -9,0 % | -5,8 % | |
| Qualität & Bilanz | ||||
| ROIC | – | -24,0 % | -23,5 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -23.517.000 | -0,50 | 452.701.000 | 437.756.000 | |
| 2025-12-31 | 10-K | -86.971.000 | -2,38 | 385.144.000 | 369.223.000 | |
| 2025-09-30 | 10-Q | -21.618.000 | -0,63 | 400.076.000 | 387.538.000 | |
| 2025-06-30 | 10-Q | -19.411.000 | -0,58 | 231.522.000 | 219.239.000 | |
| 2025-03-31 | 10-Q | -23.880.000 | -0,71 | 245.926.000 | 235.422.000 | |
| 2024-12-31 | 10-K | -61.922.000 | -5,82 | 268.535.000 | 257.442.000 | |
| 2024-09-30 | 10-Q | -18.142.000 | -2,78 | 282.400.000 | 271.368.000 | |
| 2024-06-30 | 10-Q | -15.857.000 | -12,62 | -97.885.000 | ||
| 2024-03-31 | 10-Q | -12.337.000 | -10,26 | -83.047.000 | ||
| 2023-12-31 | 10-K | -32.563.000 | -31,96 | 84.180.000 | -72.468.000 | |
| 2023-09-30 | 10-Q | -10.162.000 | -9,40 | -64.819.000 | ||
| 2023-06-30 | 10-Q | -7.608.000 | -55.390.000 | |||
| 2023-03-31 | 10-Q | -5.949.000 | -48.272.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -0,50 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | -0,63 |
| Q2 2025 | 30.06.2025 | 06.11.2025 | – | -0,58 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -0,71 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | – | -2,78 |
| Q2 2024 | 30.06.2024 | 06.11.2025 | – | -12,62 |
| Q1 2024 | 31.03.2024 | 06.11.2025 | – | -10,26 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | – | -9,40 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 12.03.2026 | 10-K | 31.12.2025 | 71 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 17.03.2025 | 10-K | 31.12.2024 | 76 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (05.06.2026)
HOCH Abgang Schlüsselpersonen (05.06.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 05.06.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 27.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | s exhibit 10.1 to this current report on Form 8-K.Item 5.02 Departure of Directors or Certain Officers; Election of… |
| 22.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 06.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | y set forth by specific reference in such filing. Item 5.02. Departure of Directors or Certain Officers; Election of… |
| 06.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 07.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 148 | 36,98 | 5.473 |
| 2026-05-04 | 18 | 29,78 | 536 |
| 2026-04-20 | 2.200 | 33,77 | 74.294 |
| 2026-03-16 | 487 | 28,00 | 13.636 |
| 2026-03-13 | 10.711 | 27,95 | 299.372 |
| 2026-03-12 | 435 | 28,94 | 12.589 |
| 2026-03-10 | 166 | 27,94 | 4.638 |
| 2026-03-06 | 191 | 31,44 | 6.005 |
| 2026-03-02 | 7.145 | 32,55 | 232.570 |
| 2026-02-26 | 2.127 | 35,64 | 75.806 |
| 2026-02-19 | 130 | 40,31 | 5.240 |
| 2026-02-13 | 117 | 38,00 | 4.446 |
| 2026-02-11 | 534 | 37,68 | 20.121 |
| 2026-02-09 | 311 | 37,67 | 11.715 |
| 2026-02-06 | 70 | 36,05 | 2.524 |
| 2026-02-05 | 74 | 38,37 | 2.839 |
| 2026-02-04 | 1 | 39,22 | 39 |
| 2026-01-20 | 17.062 | 40,53 | 691.523 |
| 2026-01-08 | 400 | 32,55 | 13.020 |
| 2026-01-05 | 1.124 | 30,55 | 34.338 |
| 2025-12-31 | 21 | 30,90 | 649 |
| 2025-12-24 | 10.891 | 32,20 | 350.690 |
| 2025-12-22 | 800 | 30,42 | 24.336 |
| 2025-12-19 | 3.477 | 28,67 | 99.686 |